Mayo Clinic researchers have developed a novel genetics-based prognostic tool for myelodysplastic syndrome. The findings are published in the October print issue of Mayo Clinic Proceedings.
from Latest Cancer News https://ift.tt/2DFSffP
No comments
Post a Comment
Thanks for comment via will connect you within 24 hours.